Drug review & submission - cder ESP PM support, technical lead, business analyst, QA
Ended Awarded Last action
- Contract number
- 75F40120F80460
- Awardee
-
DRT Strategies, Inc. UEI XMTHGDNB3QU5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,868,018
Award facts
- Contract value 100% obligated
- $3,868,017.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Arlington, VA 22203, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$46,374 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,007,855 | |
| Exercise an Option | $988,094 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $968,719 | |
| Original award | $949,723 |
About this award
The Food and Drug Administration awarded a delivery order valued at $3.9 million to DRT Strategies, Inc., a minority-owned, woman-owned small business based in Arlington, Virginia. This contract, which was awarded on August 24, 2020, and completed on September 15, 2024, supports the Center for Drug Evaluation and Research through provision of drug review and submission activities, including program management, technical leadership, business analysis, and quality assurance functions. The work is performed on a labor-hours basis at the contractor's Arlington, Virginia location, with no set-aside designation applied to this award.
This delivery order was issued under the Strategic Partners Acquisition Readiness Contract (SPARC), an FDA contracting vehicle designed to provide flexible access to professional services across the agency. DRT Strategies brings substantial experience supporting FDA missions, having previously secured multiple prime contracts with the Center for Drug Evaluation and Research and other agency divisions. The firm's demonstrated capabilities in program management, scientific support, and technical service delivery align with the specialized requirements of drug review operations within CDER, one of FDA's mission-critical divisions responsible for evaluating new pharmaceutical products.
Quick answers
Who was awarded contract 75F40120F80460?
75F40120F80460 was awarded to DRT Strategies, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 24, 2020.
How much is contract 75F40120F80460 worth?
The government has obligated $3,868,018 on 75F40120F80460.
Is contract 75F40120F80460 an order under another contract?
Yes. 75F40120F80460 is a delivery order under HHSM500201600047I, an indefinite delivery contract, on Strategic Partners Acquisition Readiness Contract (SPARC).
Was contract 75F40120F80460 competed?
The extent of competition for 75F40120F80460 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award